D1SPINK1:使

Aya Shinozaki-Ushiku1, Daizo Koinuma2, Atsuhito Nakayama2

  • 1Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Integrative Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

概括

由于细微的细胞异型,诊断氧化腺瘤具有挑战性. 这项研究确定了cyclin D1和血清酶抑制剂Kazal type 1 (SPINK1) 作为可靠的标记物,以区分这些瘤与正常腺体.

相关概念视频